Cundari Dominic R 4
4 · DiaMedica Therapeutics Inc. · Filed Feb 2, 2022
Insider Transaction Report
Form 4
Cundari Dominic R
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-01+125,000→ 125,000 totalExercise: $2.90Exp: 2032-02-01→ Common Shares (125,000 underlying) - Award
Stock Option (right to buy)
2022-02-01+40,000→ 40,000 totalExercise: $2.90Exp: 2032-02-01→ Common Shares (40,000 underlying)
Holdings
- 2,800
Voting Common Shares, no par value per share
Footnotes (2)
- [F1]This option vests with respect to 31,250 common shares on February 1, 2023 and with respect to the remaining 75% of the common shares in 36 nearly equal monthly installments commencing one month after the one-year anniversary of the grant date.
- [F2]This option vests with respect to 10,000 common shares on May 1, 2022 and with respect to the remaining 75% of the common shares in three nearly equal installments on each of August 1, 2022, November 1, 2022 and February 1, 2023.